Dreamgard provides bruxism sufferers and dentists with an effective, streamlined solution that sets a new standard of care and treatment.
Dreamgard was created as a result of a significant market gap of accessibility, affordability and effectiveness for the treatment of sleep bruxism (nighttime teeth grinding). Sleep bruxism affects 60 million people in the U.S. The current solutions available are either ineffective (OTC) or inaccessible and unaffordable (prescription). Dreamgard has created a solution that is effective, accessible and affordable, and is cleared by the FDA.